Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
|Gene Name:||napsin A aspartic peptidase|
|Family/Subfamily:||Protease , Aspartic A1|
|Synonyms:||NAPSA, Asp 4, ASP4, Aspartyl protease 4, Kdap, NAP1, Napsin A aspartic peptidase, Napsin-1, KAP, TA01/TA02, Napsin A, Napsin-A, SNAPA, NAP 1, Pronapsin A|
|Target Sequences:||NM_004851 NP_004842.1 O96009|
If you do not find the reagent or information you require, please contact firstname.lastname@example.org to inquire about additional products in development.